Advances in medical science have had a dramatic impact on the quality of care that patients receive. In the area of spinal surgery, NuVasive (NASDAQ: NUVA) has made a lot of headway with its minimally disruptive medical devices, and consistent growth has rewarded shareholders who’ve had the patience to stick with the company over the long haul.